Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells
Metrics: PDF 2171 views | HTML 2746 views | ?
Jing Chen1,*, Kai Zhang1,*, Haizhu Song1,*, Rui Wang1, Xiaoyuan Chu1, Longbang Chen1
1Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu, China
*These authors have contributed equally to this work
Long-bang Chen, email: [email protected]
Keywords: lung adenocarcinoma (LAD), lncRNA CCAT1, let-7c, chemoresistance, epithelial-to-mesenchymal transition
Received: April 23, 2016 Accepted: August 11, 2016 Published: August 23, 2016
Chemoresistance remains one of the major obstacles in clinical treatment of lung adenocarcinoma (LAD). Indeed, docetaxel-resistant LAD cells present chemoresistance and epithelial-to-mesenchymal transition phenotypes. Long non-coding RNAs (lncRNAs) are known to promote tumorigenesis in many cancer types. Here, we showed that the lncRNA colon cancer-associated transcript-1 (CCAT1) was upregulated in docetaxel-resistant LAD cells. Furthermore, downregulation of CCAT1 decreased chemoresistance, inhibited proliferation, enhanced apoptosis and reversed the epithelial-to-mesenchymal transition phenotype of docetaxel-resistant LAD cells. We also found that the oncogenic function of CCAT1 in docetaxel-resistant LAD cells depended on the sponging of let-7c. In turn, the sponging of let-7c by CCAT1 released Bcl-xl (a let-7c target), thereby promoting the acquisition of chemoresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant LAD cells. Our data reveal a novel pathway underlying chemoresistance and the epithelial-to-mesenchymal transition in docetaxel-resistant LAD cells.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.